Healthcare / Medical Care FacilitiesUpdated 2026-05-10 22:07 UTC

LON/CVSG stock hub

LON/CVSG has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/CVSGis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

790M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/CVSG

In the news

Latest news · LON/CVSG

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E12.4

P25 12.9P50 16.9P75 23.5

Trailing P/E49.2

P25 15.9P50 22.9P75 35.8

ROE6.1

P25 -54.2P50 2.1P75 13.7

ROIC4.5

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/CVSG market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

241

Groups with data

Currency

GBP

Showing 241 of 241 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	UK
Employees	9,000
Employees Change	150%
Employees Change Percent	1.69
Enterprise value	GBX 1.1B
Exchange	London Stock Exchange
Financial currency	GBP
First seen	2026-05-10
Industry	Medical Care Facilities
Isin	GB00B2863827
Last refreshed	2026-05-10
Market cap	GBX 790M
Price	GBX 1,126
Price currency	GBX
Rev Per Employee	76,977.78x
Sector	Healthcare
Sic	0700
Symbol	lon/CVSG
Website	https://www.cvsukltd.co.uk

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.25%
EV Earnings	21.36x
EV/EBIT	22.45x
EV/EBITDA	9.68x
EV/FCF	18.44x
EV/Sales	1.52x
FCF yield	7.24%
Forward P/E	12.44x
P/B ratio	2.63x
P/E ratio	49.17x
P/S ratio	1.14x
PE Ratio10 Y	69.81x
PE Ratio3 Y	94.2x
PE Ratio5 Y	70.03x
PEG ratio	1.33x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	6.78%
EBITDA Margin	13.05%
FCF margin	8.26%
Gross margin	43.24%
Gross Profit	GBX 299.6M
Gross Profit Growth	4.87%
Gross Profit Growth Q	9.67%
Gross Profit Growth3 Y	3.38%
Gross Profit Growth5 Y	3.57%
Net Income	GBX 49.4M
Net Income Growth	997.78%
Net Income Growth Q	-30.36%
Net Income Growth Years	1%
Net Income Growth3 Y	11.75%
Net Income Growth5 Y	11.01%
Pretax Margin	4.6%
Profit Margin	7.13%
Profit Per Employee	GBX 5,489
Profitable Years	17
ROA	4.16
Roa5y	5.54
ROCE	7.87
ROE	6.09
Roe5y	12
ROIC	4.5
Roic5y	8.38

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	4.21%
Cagr15y	17.93%
Cagr1y	-11.7%
Cagr3y	-17.97%
Cagr5y	-13%
Div CAGR10	10.98%
Div CAGR3	6.69%
Div CAGR5	9.1%
EPS Growth	1,002.4
EPS Growth Q	-30.17
EPS Growth Years	1
EPS Growth3 Y	11.54
EPS Growth5 Y	11
FCF Growth	98.61%
FCF Growth Q	6.07%
FCF Growth3 Y	5.36%
FCF Growth5 Y	2.48%
OCF Growth	22.38%
OCF Growth Q	0.52%
OCF Growth10 Y	0.59%
OCF Growth3 Y	-2.54%
OCF Growth5 Y	0.24%
Revenue Growth	7.06x
Revenue Growth Q	5.81x
Revenue Growth Quarters	11x
Revenue Growth Years	20x
Revenue Growth3 Y	4.16x
Revenue Growth5 Y	3.73x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	GBX 0.98
Assets	GBX 716.9M
Cash	GBX 12.3M
Current Assets	GBX 128.4M
Current Liabilities	GBX 119.9M
Debt	GBX 272.5M
Debt EBITDA	GBX 2.5
Debt Equity	GBX 0.91
Debt FCF	GBX 4.76
Equity	GBX 299.9M
Interest Coverage	3.11
Liabilities	GBX 417M
Long Term Assets	GBX 588.5M
Long Term Liabilities	GBX 297.1M
Net Cash	GBX -260.2M
Net Cash By Market Cap	GBX -32.94
Net Debt EBITDA	GBX 2.88
Net Debt Equity	GBX 0.87
Net Debt FCF	GBX 4.55
Tangible Book Value	GBX -71.6M
Tangible Book Value Per Share	GBX -1
WACC	8.1

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.07
Inventory Turnover	12.81
Net Working Capital	GBX 12M
Quick ratio	0.81
Working Capital	GBX 8.5M
Working Capital Turnover	GBX 78.73

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.04%
Dividend Growth	6.25%
Dividend Growth Years	14%
Dividend per share	GBX 0.09
Dividend Years	5
Dividend Yield	0.75%
Ex Div Date	2025-11-06
Last Dividend	GBX 0.09
Payout Frequency	Annual
Payout Ratio	12.35%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	50.99%
1Y total return	-11.7%
200-day SMA	1,256.9
3Y total return	-44.81%
50-day SMA	1,203.1
50-day SMA vs 200-day SMA	50under200
5Y total return	-50.15%
All Time High	2,835
All Time High Change	-60.28%
All Time High Date	2021-09-23
All Time Low	71
All Time Low Change	1,485.92%
All Time Low Date	2010-08-13
ATR	34.67
Beta	1.02
Beta1y	0.78
Beta2y	1
Ch YTD	-12.31
High	1,140
High52	1,648
High52 Date	2025-10-15
High52ch	-31.67%
Low	1,116
Low52	1,062
Low52 Date	2026-03-30
Low52ch	6.03%
Ma50ch	-6.41%
Price vs 200-day SMA	-10.42%
RSI	36.87
RSI Monthly	43.57
RSI Weekly	40.45
Sharpe ratio	-0.55x
Sortino ratio	-0.58
Total Return	0.71%
Tr YTD	-12.31
Tr15y	1,086.43%
Tr1m	0.36%
Tr1w	-3.76%
Tr3m	-16.96%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	GBX 47M
Operating Income Growth	-5.62
Operating Income Growth Q	-11.24
Operating Income Growth3 Y	-11.8
Operating Income Growth5 Y	-0.42
Operating margin	6.78

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	68,637,168%
Net Borrowing	-38,900,000
Shares Insiders	0.21%
Shares Institutions	92.55%
Shares Out	70,156,719
Shares Yo Y	0.04%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	GBX 55.3M
Average Volume	304,670.55x
Bv Per Share	4.12
CAPEX	GBX -25.1M
Ch10y	44.27
Ch15y	993.2
Ch1m	0.36
Ch1w	-3.76
Ch1y	-12.31
Ch3m	-16.96
Ch3y	-45.92
Ch5y	-51.47
Ch6m	-6.79
Change	-1.23%
Change From Open	-0.62
Close	1,140
Days Gap	-0.61
Depreciation Amortization	43,400,000
Dollar Volume	326,965,628
Earnings Date	2026-09-24
EBIT	GBX 47M
EBITDA	GBX 90.4M
EPS	GBX 0.69
F Score	6
FCF	GBX 57.2M
FCF EV Yield	5.42x
FCF Per Share	GBX 0.82
Financing CF	-57,800,000
Fiscal Year End	June
Founded	1,999
Goodwill	249,800,000
Graham Number	798.493
Graham Upside	-29.09
Income Tax	GBX 14.8M
Investing CF	-22,900,000
Is Primary Listing	1
Last Earnings Date	2026-02-26
Last Report Date	2025-12-31
Lynch Fair Value	GBX 757
Lynch Upside	-32.73
Ma150	1,264.4
Ma150ch	-10.95%
Ma20	1,182.6
Ma20ch	-4.78%
Net CF	700,000
Next Earnings Date	2026-09-24
Open	1,133
P FCF Ratio	13.81
P OCF Ratio	9.6
Payment Date	2025-12-05
Position In Range	41.67
Ppne	220,900,000
Price Date	2026-05-08
Price EBITDA	GBX 8.74
Relative Volume	0.95x
Revenue	692,800,000x
SBC By Revenue	0.27x
Share Based Comp	1,900,000
Tax By Revenue	2.14x
Tax Rate	46.39%
Tr6m	-6.79%
Volume	290,378
Z Score	2.88

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LON/CVSG dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.8%

$0.09 annual per share

Payout ratio

+12.3%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+9.1%

14 consecutive years of growth

Total shareholder yield

+0.7%

Next ex-dividend date: 2025-11-06

Performance

LON/CVSG stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/CVSG?

Insider, institutional, and short-interest positioning.

Institutional ownership

+92.6%

Share of float held by funds and institutions

Insider ownership

+0.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.0%

Negative means the company is buying back shares.

Technical

LON/CVSG momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

36.9

Neutral momentum band

Price vs 200-day MA

-10.4%

50/200-day relationship not available

Beta (5Y)

1.02

Moves roughly with the market

Sharpe ratio

-0.55

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/CVSG

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/CVSG stock rating?

lon/CVSG is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/CVSG analysis?

The full report lives at /stocks/lon/CVSG/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/CVSG?

The latest report frames lon/CVSG around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/CVSG page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.